These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22273347)

  • 1. A critical nursing perspective of pharmacological interventions for schizophrenia and the marginalization of person-centered alternatives.
    Harris BA
    Issues Ment Health Nurs; 2012 Feb; 33(2):127-9. PubMed ID: 22273347
    [No Abstract]   [Full Text] [Related]  

  • 2. Time to wake up and smell the coffee: antipsychotic medication and schizophrenia.
    Jones M; Grey R
    J Psychiatr Ment Health Nurs; 2008 May; 15(4):344-8. PubMed ID: 18387154
    [No Abstract]   [Full Text] [Related]  

  • 3. Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication.
    Jones M; Jones A
    J Psychiatr Ment Health Nurs; 2007 Jun; 14(4):418-23. PubMed ID: 17517033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative nursing care of patients with schizophrenia.
    Saunders JC
    AORN J; 2009 May; 89(5):893-7. PubMed ID: 19422947
    [No Abstract]   [Full Text] [Related]  

  • 5. Schizophrenia treatment guidelines in the United States.
    Moore TA
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):40-9. PubMed ID: 21459738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current concepts of pharmacological treatment in schizophrenia].
    Jarema M
    Psychiatr Pol; 2002; 36(6):857-68. PubMed ID: 12725017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subject aspects during and after acute management of schizophrenia].
    Krankenpfl J; 2002; 40(1-2):22-4. PubMed ID: 12035410
    [No Abstract]   [Full Text] [Related]  

  • 10. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P; Degiovanni A; Parrot F
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract]   [Full Text] [Related]  

  • 11. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Higher outcomes"--optimizing therapy of schizophrenia].
    Rüther E
    Krankenpfl J; 2004; 42(5-6):151. PubMed ID: 15527215
    [No Abstract]   [Full Text] [Related]  

  • 13. [Person-centered and non-directive counseling and the nurse-patient relationship].
    Schneider-Harris J
    Rech Soins Infirm; 2007 Jun; (89):52-7. PubMed ID: 17674613
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives on treatment needs in schizophrenia.
    Meise U; Fleischhacker WW
    Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
    [No Abstract]   [Full Text] [Related]  

  • 15. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonists and schizophrenia: theoretical developments for the development of mental health nursing.
    Jones M; White J; Gray R
    J Psychiatr Ment Health Nurs; 2009 Jun; 16(5):409-15. PubMed ID: 19538596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From the schizophrenic patient to the nurse's being, reflection on the protocols!].
    Touzet P
    Soins Psychiatr; 2007; (249):28-9. PubMed ID: 17438983
    [No Abstract]   [Full Text] [Related]  

  • 18. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fewer adverse effects! Treatment with atypical neuroleptics].
    Müller N; Riedel M
    Pharm Unserer Zeit; 2002; 31(6):558-65. PubMed ID: 12481513
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
    Canceil O; Limosin F; Passerieux C
    Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.